197 related articles for article (PubMed ID: 33790910)
1. Profiling Tissue and Biofluid miR-155-5p, miR-155
Crossland RE; Norden J; Ghimire S; Juric MK; Pearce KF; Lendrem C; Collin M; Mischak-Weissinger E; Holler E; Greinix HT; Dickinson AM
Front Immunol; 2021; 12():639171. PubMed ID: 33790910
[No Abstract] [Full Text] [Related]
2. Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease.
Atarod S; Norden J; Bibby LA; Janin A; Ratajczak P; Lendrem C; Pearce KF; Wang XN; O'Reilly S; Van Laar JM; Collin M; Dickinson AM; Crossland RE
Front Immunol; 2018; 9():1485. PubMed ID: 30042760
[TBL] [Abstract][Full Text] [Related]
3. Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease.
Crossland RE; Norden J; Juric MK; Green K; Pearce KF; Lendrem C; Greinix HT; Dickinson AM
Front Immunol; 2017; 8():308. PubMed ID: 28392786
[TBL] [Abstract][Full Text] [Related]
4. Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease.
Crossland RE; Norden J; Kralj Juric M; Pearce KF; Lendrem C; Bibby LA; Collin M; Greinix HT; Dickinson AM
Front Immunol; 2017; 8():1446. PubMed ID: 29176973
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-κB1 and MicroRNA-146a polymorphisms and risk of acute graft versus host disease post allogeneic stem cell transplantation.
Mossallam GI; Fattah RA; Mahmoud HK
Immunobiology; 2020 Mar; 225(2):151876. PubMed ID: 31813598
[TBL] [Abstract][Full Text] [Related]
6. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays.
Zhang C; Bai N; Huang W; Zhang P; Luo Y; Men S; Wen T; Tong H; Wang S; Tian YP
Ann Hematol; 2016 Oct; 95(11):1833-43. PubMed ID: 27553380
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease.
Wang Y; Zhao X; Ye X; Luo H; Zhao T; Diao Y; Zhang H; Lv M; Zhang W; Huang X; Wan J
Ann Hematol; 2015 Sep; 94(9):1505-14. PubMed ID: 26051902
[TBL] [Abstract][Full Text] [Related]
9. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.
Xiao B; Wang Y; Li W; Baker M; Guo J; Corbet K; Tsalik EL; Li QJ; Palmer SM; Woods CW; Li Z; Chao NJ; He YW
Blood; 2013 Nov; 122(19):3365-75. PubMed ID: 24041574
[TBL] [Abstract][Full Text] [Related]
10. Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study.
Motaei J; Kerachian MA; Mousavi SA; Alimoghadam K; Ghavamzadeh A; Manoochehrabadi S; Ahmadvand M; Yaghmaie M
Ann Hematol; 2021 Oct; 100(10):2621-2631. PubMed ID: 34247256
[TBL] [Abstract][Full Text] [Related]
11. [Plasma MiR-181b and MiR-194 As Biomarkers for Acute Graft- Versus-Host Disease and Significance of Their Changes].
Chen Y; Deng HL; Kang DL; Wang Y; Hong XL; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):957-962. PubMed ID: 34105500
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA155 is increased in patients with acute graft-versus-host disease.
Xie LN; Zhou F; Liu XM; Fang Y; Yu Z; Song NX; Kong FS
Clin Transplant; 2014 Mar; 28(3):314-23. PubMed ID: 24494749
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease.
Xie L; Zhou F; Liu X; Fang Y; Yu Z; Song N; Kong F
Cytokine; 2016 Sep; 85():37-44. PubMed ID: 27288630
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.
Ranganathan P; Ngankeu A; Zitzer NC; Leoncini P; Yu X; Casadei L; Challagundla K; Reichenbach DK; Garman S; Ruppert AS; Volinia S; Hofstetter J; Efebera YA; Devine SM; Blazar BR; Fabbri M; Garzon R
J Immunol; 2017 Mar; 198(6):2500-2512. PubMed ID: 28159900
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-155 as a potential biomarker of male fertility.
Tsatsanis C; Bobjer J; Rastkhani H; Dermitzaki E; Katrinaki M; Margioris AN; Giwercman YL; Giwercman A
Hum Reprod; 2015 Apr; 30(4):853-60. PubMed ID: 25740880
[TBL] [Abstract][Full Text] [Related]
17. miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.
Zhao XS; Wang YN; Lv M; Kong Y; Luo HX; Ye XY; Wu Q; Zhao TF; Hu YH; Zhang HY; Huo MR; Wan J; Huang XJ
Oncotarget; 2016 Jul; 7(30):48321-48334. PubMed ID: 27340781
[TBL] [Abstract][Full Text] [Related]
18. Tissue-Specific Expression Patterns of MicroRNA during Acute Graft-versus-Host Disease in the Rat.
Jalapothu D; Boieri M; Crossland RE; Shah P; Butt IA; Norden J; Dressel R; Dickinson AM; Inngjerdingen M
Front Immunol; 2016; 7():361. PubMed ID: 27695455
[TBL] [Abstract][Full Text] [Related]
19. miR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence.
Atarod S; Ahmed MM; Lendrem C; Pearce KF; Cope W; Norden J; Wang XN; Collin M; Dickinson AM
Front Immunol; 2016; 7():56. PubMed ID: 27014257
[TBL] [Abstract][Full Text] [Related]
20. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
